Royal Bank Of Canada Jaguar Health, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.08 - $809.55 $77 - $781,215	-965 Reduced 89.43%	114 $0
Q3 2022 Nov 14, 2022	BUY	$0.17 - $765.0 $170 - $767,295	1,003 Added 1319.74%	1,079 $0
Q2 2022 Aug 15, 2022	BUY	$0.27 - $0.71 $20 - $53	76 New	76 $0
Q1 2022 May 16, 2022	SELL	$0.38 - $1.07 $52 - $146	-137 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.03 - $2.48 $141 - $339	137 New	137 $0

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $127M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.